Experience with human islet transplantation in Sweden.
Tibell
A
A
Department of Transplantation Surgery, Huddinge University Hospital, Stockholm, Sweden.
Bolinder
J
J
Hagström-Toft
E
E
Tollemar
J
J
Brendel
M
M
Eckhard
M
M
Brandhorst
D
D
Bretzel
R G
RG
Korsgren
O
O
Groth
C
C
D001786:Blood Glucose / Q000378:metabolism; D002096:C-Peptide / Q000097:blood; D002469:Cell Separation / Q000379:methods; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival / Q000502:physiology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000166:cytology; D016381:Islets of Langerhans Transplantation / Q000401:mortality / Q000502:physiology / Q000706:statistics & numerical data*; D016030:Kidney Transplantation; D012189:Retrospective Studies; D013548:Sweden; D013997:Time Factors; D020858:Tissue and Organ Harvesting / Q000379:methods; D014184:Transplantation, Homologous
D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D007166:Immunosuppressive Agents; D007328:Insulin